Koers Clal Biotechnology Industries Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
CBI
IL0011042806
Holdingvennootschappen
Omzet 2022 | 370K 99,55K 92,43K | Omzet 2023 | 104K 27,98K 25,98K | Marktkapitalisatie | 62,27 mln. 16,75 mln. 15,56 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -61 mln. -16,41 mln. -15,24 mln. | Nettowinst (verlies) 2023 | -31 mln. -8,34 mln. -7,74 mln. | EV/omzet 2022 | 331 x |
Nettoschuld 2022 | 23,85 mln. 6,42 mln. 5,96 mln. | Nettoschuld 2023 | 22,4 mln. 6,03 mln. 5,6 mln. | EV/omzet 2023 | 814 x |
K/w-verhouding 2022 |
-1,6
x | K/w-verhouding 2023 |
-2,01
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 34,65% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Assaf Segal
CEO | Chief Executive Officer | 51 | 01-07-15 |
Liat Nissan
DFI | Director of Finance/CFO | 46 | - |
Arnon Aharon
CTO | Chief Tech/Sci/R&D Officer | 55 | 01-01-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 67 | 09-05-03 | |
Yuval Yanai
BRD | Director/Board Member | 71 | 18-11-15 |
Gad Keren
BRD | Director/Board Member | 73 | 17-02-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,08% | 78,53 mld. | |
+67,28% | 18,53 mld. | |
+10,98% | 16,56 mld. | |
+10,92% | 14,23 mld. | |
+3,79% | 12,82 mld. | |
+9,14% | 12,01 mld. | |
+9,87% | 11,19 mld. | |
+39,26% | 10,33 mld. | |
-0,80% | 9,73 mld. |